Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vaginal Hyal gel is a **topical vaginal gel** containing **hyaluronic acid** (as sodium hyaluronate) designed for the treatment and prevention of **vaginal dryness, itching, irritation, and atrophy**, particularly in peri- and postmenopausal women. **Hyaluronic acid** is a glycosaminoglycan naturally involved in tissue hydration and repair. The gel provides mucosal hydration, supports epithelial repair, and helps restore physiological vaginal conditions. **Arginine** is included to promote local vasodilation, enhancing microcirculation and potentially improving sexual arousal. The gel is formulated for intravaginal use as a non-hormonal alternative to estrogen-based therapies, improving symptoms and quality of life without systemic hormonal effects. Clinical studies show benefit in reducing dryness and atrophic symptoms, with favorable tolerability and safety profiles[1][2][3][4][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vaginal hyal gel.